Butyrylcholinesterase 抗体 (N-Term)
Quick Overview for Butyrylcholinesterase 抗体 (N-Term) (ABIN630462)
抗原
See all Butyrylcholinesterase (BCHE) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- BCHE antibody was raised against the N terminal of BCHE
-
纯化方法
- Purified
-
免疫原
- BCHE antibody was raised using the N terminal of BCHE corresponding to a region with amino acids SSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQ
-
-
-
-
应用备注
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
BCHE Blocking Peptide, (ABIN5612293), is also available for use as a blocking control in assays to test for specificity of this BCHE antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCHE antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Butyrylcholinesterase (BCHE)
-
别名
- BCHE
-
背景
- Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
-
分子量
- 68 kDa (MW of target protein)
-
途径
- Peptide Hormone Metabolism
抗原
-